Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E-selectin Measurement
|
6 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.800 | 1.000 | 2 | 2010 | 2017 | ||||||
Serum total cholesterol measurement
|
1243 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.800 | 1.000 | 2 | 2012 | 2018 | ||||||
Coronary heart disease
|
1178 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 2 | 2011 | 2011 | ||||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 2 | 2011 | 2018 | ||||||
Serum albumin measurement
|
3282 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 2 | 2011 | 2013 | ||||||
Venous Thromboembolism
|
408 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 2 | 2011 | 2012 | ||||||
Activated Partial Thromboplastin Time measurement
|
44 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
Alkaline phosphatase measurement
|
79 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
C-reactive protein measurement
|
624 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Corpuscular Hemoglobin Concentration Mean
|
4389 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
Factor VIII measurement
|
42 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
Fasting blood glucose measurement
|
212 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||
Ferritin measurement
|
21 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||
Hematocrit procedure
|
216 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
P-Selectin Measurement
|
2 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
Serum ferritin measurement
|
21 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||
Vascular Endothelial Growth Factor Receptor 2 Measurement
|
2 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
Venous Thrombosis
|
218 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
von Willebrand's factor (lab test)
|
427 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
Ischemic stroke
|
704 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.010 | 1 | 2018 | 2018 | |||||||
Large-artery atherosclerosis (embolus/thrombosis)
|
35 | 0.851 | 0.160 | 9 | 133278431 | upstream gene variant | T/A;C | snv | 0.010 | 1.000 | 1 | 2016 | 2016 |